Value Sense
HIMS
Hims & Hers Health, Inc. (HIMS)
Last Price$40.7(9.8%)
Market Cap$9,261.6M
LTM P/E
73.5x
EPS growth
N/A
PEGY
N/A
Peter Lynch Fair Value
N/A
Overvalued (Peter Lynch formula)
(100.0%)
Stock quality
7/10
Great
HIMS
is 45.4% overvalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

HIMS Peter Lynch Fair Value

Peter Lynch Fair Value Assumptions

as of Mar 10, 2025
LTM P/E
73.5x
EPS growth
N/A
Dividend Yield
0.0%
PEGY
N/A
Last share price
$40.7
Peter Lynch Fair Value
N/A
100% overvalued

Peter Lynch Fair Value Calculation

PEGY
N/A
=
LTM P/E
73.5x
/
(
EPS growth
N/A
+
Dividend yield
0.00%
)
Peter Lynch
Fair Value
N/A
=
Last share price
$40.7
/
PEGY
N/A

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Low P/E stocks

Low P/E stocks

Explore the best low P/E stocks to buy in 2025, featuring top companies trading at low P/E ratios.

3M Return 7.5%
S&P Outperformance -5.5%
Next 3M Predicted Return 10.2%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%

HIMS EPS growth & Dividend Yield

Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
EPS growth
Dividend Yield

HIMS vs Peer Set: Peter Lynch Fair Value Comparison

General

PETER LYNCH FAIR VALUE

Financial metrics

Company name

Undervaluation / Overvaluation

Revenue growth

EBITDA margin

Net Income margin

Hims & Hers Health, Inc. logo
Hims & Hers Health, Inc.HIMS
N/A
65.5%
(65.6%)
(2.7%)
Median Peer Set
2.1%
(4.3%)
10.2%
The Clorox Company logo
The Clorox CompanyCLX
95.8%
(4.0%)
86.0%
3.9%
Unilever PLC logo
Unilever PLCUL
71.9%
1.8%
(12.4%)
10.9%
Church & Dwight Co., Inc. logo
Church & Dwight Co., Inc.CHD
(34.1%)
4.1%
(22.7%)
9.6%
e.l.f. Beauty, Inc. logo
e.l.f. Beauty, Inc.ELF
11.3%
76.9%
99.1%
12.5%
The Procter & Gamble Company logo
The Procter & Gamble CompanyPG
(72.0%)
2.5%
3.8%
17.7%
Kimberly-Clark Corporation logo
Kimberly-Clark CorporationKMB
(72.0%)
(1.8%)
45.5%
12.7%
Colgate-Palmolive Company logo
Colgate-Palmolive CompanyCL
(60.8%)
3.3%
27.0%
14.4%
Kenvue Inc. logo
Kenvue Inc.KVUE
31.2%
0.1%
(40.0%)
6.7%
Coty Inc. logo
Coty Inc.COTY
(65.2%)
10.2%
(85.0%)
1.5%
The Estée Lauder Companies Inc. logo
The Estée Lauder Companies Inc.EL
(258.7%)
(1.9%)
(61.2%)
2.5%

Explore more intrinsic value tools hub for HIMS

Margin of safety
Ben Graham Fair Value
Earnings growth model
Discount rate
Peter Lynch charts
Reverse DCF
Earnings Power Value
Intrinsic Value
DCF value calculator
Relative Value

FAQ

What is Hims & Hers Health, Inc. fair value by Peter Lynch formula?

As of Mar 03, 2025, Hims & Hers Health, Inc.'s fair value using the Peter Lynch formula is N/A per share. The current price of $40.7 suggests Hims & Hers Health, Inc. may be overvalued by this metric.

What is Hims & Hers Health, Inc. Price to Earnings (P/E) ratio?

As of Mar 03, 2025, Hims & Hers Health, Inc.'s P/E ratio is 73.5x. This is calculated by dividing the current share price of $40.7 by the Earnings per Share (EPS) for the trailing twelve months, which is $0.6. The P/E ratio indicates how much investors are willing to pay for each dollar of earnings.

What is Hims & Hers Health, Inc. earnings per share (EPS)?

Hims & Hers Health, Inc. earnings per share (EPS) for the twelve months ending Mar 03, 2025, was $0.6, a N/A growth year-over-year.